Clinical Trials Logo

Clinical Trial Summary

The aim of this study was to determine whether grape seed extract (GSE) supplementation could reduce the blood pressure (BP) in response to static exercise and post exercise muscular ischemia (PEMI) in normotensive young adults. In 12 healthy subjects (7 male and 5 female, 24.6±3.4 yr), we compared acute effect of both GSE (600 mg) and placebo (PL: 600 mg) on changes from rest in systolic BP (SBP), diastolic BP (DBP), mean arterial pressure (MAP), heart rate (HR), stroke volume (SV), cardiac output (CO), and total peripheral resistance (TPR) during static exercise (SE) and PEMI. Subjects completed 2 min of SE at 30% of maximal voluntary contraction (MVC) followed by 2 min of PEMI.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05945771
Study type Interventional
Source California Baptist University
Contact
Status Completed
Phase N/A
Start date May 1, 2022
Completion date August 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT03003988 - Physiological Effects of Creatine Supplementation in Active Males N/A
Not yet recruiting NCT06256744 - Resistance Exercise-induced Anabolism in Youths and Adults N/A
Completed NCT03326934 - Impact of Dark Chocolate on Visual Performance N/A
Completed NCT05116150 - Effects of Combined Grape Seed Extract and L-citrulline Supplementation on Hemodynamic Responses in Young Males N/A
Completed NCT04988919 - Consumption of 4D Dietary Supplement on Perceptual-Cognitive and Visual-Motor Performance N/A